Hematopoietic cytokine receptor signaling

被引:204
作者
Baker, S. J.
Rane, S. G.
Reddy, E. P.
机构
[1] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA
[2] NIDDK, NIH, Diabet Branch, Bethesda, MD USA
关键词
hematopoiesis; cytokine receptors; Src kinases; JAKs; STATs;
D O I
10.1038/sj.onc.1210757
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hematopoiesis is the cumulative result of intricately regulated signaling pathways that are mediated by cytokines and their receptors. Proper culmination of these diverse pathways forms the basis for an orderly generation of different cell types. Recent studies conducted over the past 10 - 15 years have revealed that hematopoietic cytokine receptor signaling is largely mediated by a family of tyrosine kinases termed Janus kinases ( JAKs) and their downstream transcription factors termed STATs ( signal transducers and activators of transcription). Aberration in these pathways, such as that caused by the recently identified JAK2V617F mutation, is an underlying cause for diseases such as leukemias and other myeloproliferative disorders. This recent discovery, when coupled with the fact that STATs are activated by oncoproteins such as BCR-ABL, underscores the importance of the JAK- STAT pathway in both normal cellular development and disease states.
引用
收藏
页码:6724 / 6737
页数:14
相关论文
共 130 条
  • [1] Genome-wide analysis of STAT target genes - Elucidating the mechanism of STAT-mediated oncogenesis
    Alvarez, JV
    Frank, DA
    [J]. CANCER BIOLOGY & THERAPY, 2004, 3 (11) : 1045 - 1050
  • [2] Roles of the N and C terminal domains of the interleukin-3 receptor alpha chain in receptor function
    Barry, SC
    Korpelainen, E
    Sun, Q
    Stomski, FC
    Moretti, PAB
    Wakao, H
    DAndrea, RJ
    Vadas, MA
    Lopez, AF
    Goodall, GJ
    [J]. BLOOD, 1997, 89 (03) : 842 - 852
  • [3] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
    Baxter, EJ
    Scott, LM
    Campbell, PJ
    East, C
    Fourouclas, N
    Swanton, S
    Vassiliou, GS
    Bench, AJ
    Boyd, EM
    Curtin, N
    Scott, MA
    Erber, WN
    Green, AR
    [J]. LANCET, 2005, 365 (9464) : 1054 - 1061
  • [4] Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs
    Blalock, WL
    Weinstein-Oppenheimer, C
    Chang, F
    Hoyle, PE
    Wang, XY
    Algate, PA
    Franklin, RA
    Oberhaus, SM
    Steelman, LS
    McCubrey, JA
    [J]. LEUKEMIA, 1999, 13 (08) : 1109 - 1166
  • [5] Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma
    Bromberg, JF
    Horvath, CM
    Wen, ZL
    Schreiber, RD
    Darnell, JE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) : 7673 - 7678
  • [6] ACTIVATION OF THE STAT3 ACUTE-PHASE RESPONSE FACTOR TRANSCRIPTION FACTOR BY INTERLEUKIN-5
    CALDENHOVEN, E
    VANDIJK, T
    RAAIJMAKERS, JAM
    LAMMERS, JWJ
    KOENDERMAN, L
    DEGROOT, RP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (43) : 25778 - 25784
  • [7] Cao XM, 1996, MOL CELL BIOL, V16, P1595
  • [8] Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl
    Carlesso, N
    Frank, DA
    Griffin, JD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) : 811 - 820
  • [9] Src kinases and not JAKs activate STATs during IL-3 induced myeloid cell proliferation
    Chaturvedi, P
    Reddy, MVR
    Reddy, EP
    [J]. ONCOGENE, 1998, 16 (13) : 1749 - 1758
  • [10] Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs
    Chaturvedi, P
    Sharma, S
    Reddy, EP
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (06) : 3295 - 3304